Orthopediatrics Q3 2026 Results: Net Loss of $5.93M, Loss Narrows
OrthoPediatrics Corp. reported net revenue of $72.7 million for the third quarter of 2026, a 19% increase compared to the same period in 2025. While the company remains in a net loss position ($5.9 million for Q3 2026), it significantly narrowed its operating loss from $9.4 million to $4.2 million year-over-year.
- Key figure
- Net loss $5.93M